We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
114.45%
This Fund
S&P 500
This Quarter
Est. Return
+12.45%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$620M
AUM Growth
-$22.5M
(-3.5%)
Cap. Flow
-$102M
Cap. Flow
% of AUM
-16.42%
Top 10 Holdings %
Top 10 Hldgs %
56.57%
Holding
63
New
7
Increased
6
Reduced
34
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XENT
Intersect ENT, Inc
XENT
|
+$8.69M |
| 2 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
+$5.06M |
| 3 |
Veracyte
VCYT
|
+$3.37M |
| 4 |
Invesco S&P SmallCap Health Care ETF
PSCH
|
+$2.38M |
| 5 |
CLLS
Cellectis
CLLS
|
+$2.19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tandem Diabetes Care
TNDM
|
+$57.3M |
| 2 |
NeoGenomics
NEO
|
+$20.2M |
| 3 |
AtriCure
ATRC
|
+$13M |
| 4 |
Ligand Pharmaceuticals
LGND
|
+$11.9M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
+$9.28M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 83.6% |
| 2 | Communication Services | 3.41% |
| 3 | Energy | 0.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LHCG
26
DELISTED
LHC Group LLC
LHCG
| $5.56M | 0.9% |
53,947
-413
| -0.8% | -$38.6K |
|
27
Bio-Techne
TECH
$11.2B
| $5.15M | 0.83% |
100,864
-63,492
| -39% | -$2.81M |
|
|
BLUE
28
DELISTED
bluebird bio
BLUE
| $4.85M | 0.78% |
2,564
-11
| -0.4% | -$22.7K |
|
29
Vertex Pharmaceuticals
VRTX
$121B
| $4.78M | 0.77% |
24,787
-187
| -0.7% | -$33.3K |
|
|
TLGT
30
DELISTED
Teligent, Inc
TLGT
| $4.52M | 0.73% |
114,510
-593
| -0.5% | -$23.8K |
|
31
OrthoPediatrics
KIDS
$519M
| $4.52M | 0.73% |
123,241
-867
| -0.7% | -$26.6K |
|
|
SGMO
32
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $4.51M | 0.73% |
265,877
+110,529
| +71% | +$1.68M |
|
|
NXTM
33
DELISTED
NxStage Medical Inc.
NXTM
| $4.22M | 0.68% |
151,207
-1,241
| -0.8% | -$34.9K |
|
34
QuidelOrtho
QDEL
$1.14B
| $3.58M | 0.58% |
54,878
-25,877
| -32% | -$1.81M |
|
35
HealthStream
HSTM
$819M
| $2.82M | 0.46% |
90,986
-649
| -0.7% | -$19.4K |
|
36
iShares Biotechnology ETF
IBB
$9.34B
| $2.6M | 0.42% |
21,291
| – | – |
|
|
37
Invesco S&P SmallCap Health Care ETF
PSCH
$163M
| $2.43M | 0.39% |
+51,855
| New | +$2.38M |
|
|
CLLS
38
Cellectis
CLLS
$277M
| $2.15M | 0.35% |
+76,325
| New | +$2.19M |
|
39
LeMaitre Vascular
LMAT
$2.32B
| $1.92M | 0.31% |
49,617
-379
| -0.8% | -$13.7K |
|
40
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
| $1.74M | 0.28% |
18,241
| – | – |
|
41
iShares US Medical Devices ETF
IHI
$3.13B
| $1.72M | 0.28% |
45,480
| – | – |
|
42
Alkermes
ALKS
$8.22B
| $1.36M | 0.22% |
32,032
-239
| -0.7% | -$10.4K |
|
43
Simulations Plus
SLP
$369M
| $1.16M | 0.19% |
+57,548
| New | +$1.12M |
|
44
Catheter Precision
VTAK
$906K
| – | – |
0
| – | – |
|
|
ENZ
45
DELISTED
Enzo Biochem, Inc.
ENZ
| $775K | 0.13% |
188,159
-1,441
| -0.8% | -$6.55K |
|
46
AbbVie
ABBV
$443B
| $393K | 0.06% |
4,159
| – | – |
|
47
Pfizer
PFE
$143B
| $377K | 0.06% |
9,020
| – | – |
|
|
DYNT
48
DELISTED
Dynatronics Corp
DYNT
| $316K | 0.05% |
22,162
+385
| +2% | +$5.59K |
|
49
Novartis
NVS
$297B
| $308K | 0.05% |
3,986
| – | – |
|
50
Merck
MRK
$322B
| $305K | 0.05% |
4,500
| – | – |
|
Similar funds
AIM
MTCM
CNC
C
RIM
CT
SL
HH
First Light Asset Management's Q3 2018 Portfolio in Review
As of Q3 2018, First Light Asset Management held 63 positions worth $620M, down 3.5% from $642M the previous quarter. Its ten largest holdings account for 57% of the portfolio.
First Light Asset Management withdrew a net $102M in Q3 2018, closing 4 positions and reducing 34 holdings. Its most notable exit was NEVRO CORP., an estimated $9.28M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 84% of assets, down from 85% a quarter earlier, followed by Communication Services and Energy.
Against the trend, First Light Asset Management opened a new position in Invesco S&P SmallCap Health Care ETF worth $2.43M.
- First Light Asset Management's largest Q3 2018 buy was Invesco S&P SmallCap Health Care ETF: 51,855 shares worth $2.43M.
- First Light Asset Management added most to Intersect ENT, Inc in Q3 2018, an estimated $8.69M increase.
- First Light Asset Management's biggest Q3 2018 reduction was Tandem Diabetes Care, cutting an estimated $57.3M.
- First Light Asset Management fully exited NEVRO CORP. in Q3 2018, selling an estimated $9.28M.
- First Light Asset Management's ten largest holdings make up 57% of its $620M portfolio in Q3 2018.
- First Light Asset Management opened 7 new positions and closed 4 in Q3 2018.
- First Light Asset Management's portfolio value fell 3.5% quarter-over-quarter to $620M.
Based on First Light Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.